Edgewise Therapeutics Patents – Insights & Stats

Edgewise Therapeutics has a total of 59 patents globally, out of which 8 have been granted. Of these 59 patents, more than 83% patents are active. The United States of America is where Edgewise Therapeutics has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Edgewise Therapeutics.

Edgewise Therapeutics was founded in 2017. Edgewise Therapeutics is a biotechnology company. The company concentrated on the identification, creation, and marketing of novel therapies for severe, uncommon muscular illnesses, which have a substantial unmet medical need.

Do read about some of the most popular patents of Edgewise Therapeutics which have been covered by us in this article and also you can find Edgewise Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Edgewise Therapeutics patent portfolio.

How many patents does Edgewise Therapeutics have?

Edgewise Therapeutics has a total of 59 patents globally. These patents belong to 10 unique patent families. Out of 59 patents, 49 patents are active.

How Many Patents Did Edgewise Therapeutics File Every Year?

Edgewise Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEdgewise Therapeutics Applications FiledEdgewise Therapeutics Patents Granted
20232
202295
2021241
20204
201922

How many Edgewise Therapeutics patents are Alive/Dead?

Worldwide Patents

Edgewise Therapeutics Patent Portfolio

How Many Patents Did Edgewise Therapeutics File in Different Countries?

Edgewise Therapeutics Worldwide Patent Filing

Countries in which Edgewise Therapeutics Filed Patents

CountryPatent
United States Of America10
Europe9
Japan8
India3
Canada3
Hong Kong (S.A.R.)3
Australia3
Brazil2
Singapore2
South Africa2
Mexico2
Israel2

Where are Research Centers of Edgewise Therapeutics Patents Located?

The Research Centers of EdgewiseTherapeutics Patents is the United States of America.

What are Edgewise Therapeutics key innovation segments?

What Technologies are Covered by Edgewise Therapeutics?

The chart below distributes patents filed by Edgewise Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Edgewise Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Edgewise Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Edgewise Therapeutics?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.